Heart failure (HF) is a long-term clinical syndrome, with increasing prevalence and considerable healthcare costs that are fur- ther expected to increase dramatically. Despite significant advances in therapy and prevention, mortality and morbidity re- main high and quality of life poor. Epidemiological data, that is, prevalence, incidence, mortality, and morbidity, show geo- graphical variations across the European countries, depending on differences in aetiology, clinical characteristics, and treatment. However, data on the prevalence of the disease are scarce, as are those on quality of life. For these reasons, the ESC-HFA has developed a position paper to comprehensively assess our understanding of the burden of HF in Europe, in order to guide future policies for this syndrome. This manuscript will discuss the available epidemiological data on HF prev- alence, outcomes, and human costs—in terms of quality of life—in European countries.

Impact analysis of heart failure across European countries: an ESC-HFA position paper / G.M.C. Rosano, P. Seferovic, G. Savarese, I. Spoletini, Y. Lopatin, F. Gustafsson, A. Bayes-Genis, T. Jaarsma, M. Abdelhamid, A.G. Miqueo, M. Piepoli, C.G. Tocchetti, A.D. Ristic, E. Jankowska, B. Moura, L. Hill, G. Filippatos, M. Metra, D. Milicic, T. Thum, O. Chioncel, T. Ben Gal, L.H. Lund, D. Farmakis, W. Mullens, S. Adamopoulos, M. Bohm, A. Norhammar, A. Bollmann, A. Banerjee, A.P. Maggioni, A. Voors, A.C. Solal, A.J.S. Coats. - In: ESC HEART FAILURE. - ISSN 2055-5822. - 9:5(2022), pp. 2767-2778. [10.1002/EHF2.14076]

Impact analysis of heart failure across European countries: an ESC-HFA position paper

M. Piepoli;
2022

Abstract

Heart failure (HF) is a long-term clinical syndrome, with increasing prevalence and considerable healthcare costs that are fur- ther expected to increase dramatically. Despite significant advances in therapy and prevention, mortality and morbidity re- main high and quality of life poor. Epidemiological data, that is, prevalence, incidence, mortality, and morbidity, show geo- graphical variations across the European countries, depending on differences in aetiology, clinical characteristics, and treatment. However, data on the prevalence of the disease are scarce, as are those on quality of life. For these reasons, the ESC-HFA has developed a position paper to comprehensively assess our understanding of the burden of HF in Europe, in order to guide future policies for this syndrome. This manuscript will discuss the available epidemiological data on HF prev- alence, outcomes, and human costs—in terms of quality of life—in European countries.
Epidemiology; Heart failure; Impact; Morbidity; Mortality; Prognosis; Quality of life
Settore MED/11 - Malattie dell'Apparato Cardiovascolare
2022
Article (author)
File in questo prodotto:
File Dimensione Formato  
ESC+Heart+Failure+-+2022+-+Rosano+-+Impact+analysis+of+heart+failure+across+European+countries++an+ESC‐HFA+position+paper+copy_compressed.pdf

accesso aperto

Descrizione: Review
Tipologia: Publisher's version/PDF
Dimensione 409.36 kB
Formato Adobe PDF
409.36 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/957297
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 21
  • ???jsp.display-item.citation.isi??? 13
social impact